SIM
Sonora Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $5.49M | Sell |
163,703
-4,962
| -3% | -$166K | 0.69% | 56 |
|
|
2021
Q2 | $6.73M | Buy |
168,665
+4,742
| +3% | +$189K | 0.88% | 44 |
|
|
2021
Q1 | $7.37M | Buy |
163,923
+12,928
| +9% | +$581K | 0.58% | 62 |
|
|
2020
Q4 | $8.54M | Buy |
150,995
+20,796
| +16% | +$1.18M | 0.71% | 46 |
|
|
2020
Q3 | $6.18M | Buy |
130,199
+19,521
| +18% | +$926K | 0.57% | 58 |
|
|
2020
Q2 | $6.53M | Sell |
110,678
-1,584
| -1% | -$93.4K | 0.67% | 52 |
|
|
2020
Q1 | $5.31M | Sell |
112,262
-3,501
| -3% | -$166K | 0.63% | 49 |
|
|
2019
Q4 | $6.99M | Sell |
115,763
-1,246
| -1% | -$75.3K | 0.66% | 50 |
|
|
2019
Q3 | $7.01M | Buy |
117,009
+4,201
| +4% | +$252K | 0.73% | 41 |
|
|
2019
Q2 | $7.25M | Sell |
112,808
-785
| -0.7% | -$50.5K | 0.81% | 39 |
|
|
2019
Q1 | $9.22M | Sell |
113,593
-673
| -0.6% | -$54.6K | 1.13% | 20 |
|
|
2018
Q4 | $6.18M | Sell |
114,266
-3,168
| -3% | -$171K | 0.9% | 32 |
|
|
2018
Q3 | $6.06M | Sell |
117,434
-718
| -0.6% | -$37K | 0.84% | 36 |
|
|
2018
Q2 | $4.92M | Sell |
118,152
-500
| -0.4% | -$20.8K | 0.76% | 47 |
|
|
2018
Q1 | $5.23M | Sell |
118,652
-461
| -0.4% | -$20.3K | 0.83% | 42 |
|
|
2017
Q4 | $5.99M | Buy |
119,113
+1,034
| +0.9% | +$52K | 0.96% | 30 |
|
|
2017
Q3 | $5.99M | Sell |
118,079
-1,779
| -1% | -$90.2K | 1.04% | 28 |
|
|
2017
Q2 | $6.1M | Buy |
119,858
+141
| +0.1% | +$7.17K | 1.15% | 27 |
|
|
2017
Q1 | $4.81M | Sell |
119,717
-1,986
| -2% | -$79.8K | 0.93% | 33 |
|
|
2016
Q4 | $5.82M | Sell |
121,703
-3,110
| -2% | -$149K | 1.2% | 28 |
|
|
2016
Q3 | $4.57M | Buy |
124,813
+1,245
| +1% | +$45.6K | 0.96% | 33 |
|
|
2016
Q2 | $2.88M | Buy |
123,568
+645
| +0.5% | +$15K | 0.66% | 44 |
|
|
2016
Q1 | $5.3M | Sell |
122,923
-3,840
| -3% | -$165K | 1.27% | 27 |
|
|
2015
Q4 | $7.85M | Sell |
126,763
-341
| -0.3% | -$21.1K | 2.04% | 10 |
|
|
2015
Q3 | $6.62M | Buy |
+127,104
| New | +$6.62M | 2% | 15 |
|